Anbio Biotechnology Class A Ordinary Shares Market Cap ($154.06 Million)
Market Cap & Net Worth: Anbio Biotechnology Class A Ordinary Shares (NNNN)
Anbio Biotechnology Class A Ordinary Shares market cap. Anbio Biotechnology Class A Ordinary Shares (NASDAQ:NNNN) has a market capitalization of $154.06 Million ($154.06 Million) as of November 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #17382 globally and #4120 in its home market, demonstrating a -7.87% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Anbio Biotechnology Class A Ordinary Shares's stock price $3.51 by its total outstanding shares 43891200 (43.89 Million). Also see NNNN cash flow metrics for how efficiently the company converts equity into cash flow.
Anbio Biotechnology Class A Ordinary Shares Market Cap History (2025–2026)
Anbio Biotechnology Class A Ordinary Shares market cap history from 2025 to 2026. Data shows change from $1.32 Billion to $154.06 Million (-24.60% CAGR). Check Anbio Biotechnology Class A Ordinary Sha share price for real-time trading data and today's change.
Index Memberships
Anbio Biotechnology Class A Ordinary Shares is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.60 Trillion | 0.01% | #473 of 976 |
Weight: Anbio Biotechnology Class A Ordinary Shares's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Anbio Biotechnology Class A Ordinary Shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Anbio Biotechnology Class A Ordinary Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Anbio Biotechnology Class A Ordinary Sha equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
135.25x
Anbio Biotechnology Class A Ordinary Shares's market cap is 135.25 times its annual revenue
Latest Price to Earnings (P/E) Ratio
182.63x
Anbio Biotechnology Class A Ordinary Shares's market cap is 182.63 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $1.32 Billion | $9.76 Million | $7.23 Million | 135.25x | 182.63x |
Competitor Companies of NNNN by Market Capitalization
Companies near Anbio Biotechnology Class A Ordinary Shares in the global market cap rankings as of November 3, 2026. Also see Anbio Biotechnology Class A Ordinary Sha assets under control for a full breakdown of the balance sheet.
Key companies related to Anbio Biotechnology Class A Ordinary Shares by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #175 globally with a market cap of $132.26 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #249 globally with a market cap of $101.18 Billion USD ( €86.54 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #419 globally with a market cap of $67.43 Billion USD ( €57.68 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #537 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #175 | Intuitive Surgical Inc | NASDAQ:ISRG | $132.26 Billion | $436.87 |
| #249 | EssilorLuxottica S. A. | PA:EL | $101.18 Billion | €186.90 |
| #419 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $67.43 Billion | €93.00 |
| #537 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Market Capitalization of Anbio Biotechnology Class A Ordinary Shares (2025–2026)
Market capitalization of Anbio Biotechnology Class A Ordinary Shares from 2025 to today. Between 2025 and today, Anbio Biotechnology Class A Ordinary Shares's market cap moved from $1.32 Billion to $ 154.06 Million, with a yearly change of -24.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $154.06 Million | -88.33% |
| 2025 | $1.32 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Anbio Biotechnology Class A Ordinary Shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $154.06 Million USD |
| MoneyControl | $154.06 Million USD |
| MarketWatch | $154.06 Million USD |
| marketcap.company | $154.06 Million USD |
| Reuters | $154.06 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/… Read more